|
Who Should Attend?
The interactive workshops will explore the
USP excipient GMP requirements and will
review the various methods of ensuring conformance,
emphasizing site audit. The USP excipient
GMPs were developed from the IPEC Good Manufacturing
Practices Guide for Bulk Pharmaceutical
Excipients which serves as the basis for
this workshop.
Both
workshops will emphasize excipient GMP auditing
techniques. They are intended for pharmaceutical
and chemical company auditors whose duties
require them to asses the practices followed
in excipient manufacturing. Distributors
of food, drug and dietary supplement ingredients
and products who wish to asses the practices
of companies they represent should also
attend.
Half-day
workshop attendees will learn how to focus
an excipient audit on the most significant
compliance issues typically found at such
manufacturing sites. Those from excipient
user companies, for example, will benefit
by learning how to conduct more effective
audits. Makers of excipients for use in
pharmaceuticals will gain an understanding
of where their resources may need to be
refocused to prove GMP compliance and distributors
will be better equipped to assess whether
their suppliers' practices are adequate
to offer the material as excipient grade.
The
full-day workshop will begin with a detailed
discussion of the half-day workshop content
and include added details on common site
deficiencies and requirements to achieve
a minimal level of excipient GMP compliance.
At the completion of the full-day workshop,
attendees will be able to focus on the compliance
issues that are important to the manufacture
of excipients as opposed to those of API
or dosage form manufacture. Participants
also will gain an understanding of risk-based
excipient auditing and thereby should be
able to assess an excipient GMP quality
system to ascertain if it can achieve a
satisfactory level of compliance for one
to consider a chemical as an excipient ingredient.
Workshop materials will be based on IPEC
GMP Guide standards as set forth in USP28/NF23
chapter <1078>. Irwin
Silverstein, Ph.D.,
IPEA COO, will present the workshops.
|
***Register
early. Attendance space limited to
first 30 registrants to allow ample
discussion opportunities among participants.***
|
|